QL
RARE icon

Quarry LP’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quarry LP’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$835K Buy
25,000
+3,750
+18% +$93.1K 0.07% 100
2026
Q1 		$445K Buy
21,250
+16,250
+325% +$366K 0.08% 174
2025
Q4 		$115K Buy
5,000
+4,890
+4,445% +$161K 0.02% 398
2025
Q3 		$3.31K Buy
+110
New +$3.3K ﹤0.01% 1919
2025
Q1 		– Sell
-2,000
Closed -$84.1K – 1945
2024
Q4 		$84.1K Buy
+2,000
New +$99.2K 0.01% 507
2024
Q2 		– Sell
-2,500
Closed -$117K – 2042
2024
Q1 		$117K Buy
2,500
+300
+14% +$14.2K 0.02% 216
2023
Q4 		$105K Sell
2,200
-2,000
-48% -$77.5K 0.02% 191
2023
Q3 		$150K Buy
+4,200
New +$166K 0.03% 168

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Quarry LP's RARE Position: Q2 2026 in Review

Quarry LP increased its Ultragenyx Pharmaceutical (RARE) stake by 18% in Q2 2026, buying an estimated $93.1K and bringing the position to 25,000 shares worth $835K. The position accounts for 0.07% of the portfolio, ranked #100.

Quarry LP first reported a position in RARE in Q3 2023 and has held it in 8 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Quarry LP held 25,000 shares of Ultragenyx Pharmaceutical worth $835K as of Q2 2026.
  • Quarry LP bought 3,750 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $93.1K.
  • Ultragenyx Pharmaceutical made up 0.07% of Quarry LP's portfolio in Q2 2026, its #100 holding.
  • Quarry LP first reported a position in Ultragenyx Pharmaceutical in Q3 2023 and has held it in 8 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.